TrialScientific reports2025

Dapagliflozin prevents vascular ischemia-reperfusion injury in healthy young males: a randomized, placebo-controlled, double-blinded trial.

Martin Lutnik et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.